Gov’t Consults May Be Pricey, But They Speed Review Times – Japan Officials
This article was originally published in The Gray Sheet
Executive Summary
U.S. companies should take advantage of Japan's review consultation program to speed device approval and avoid unnecessary duplication of clinical trials, top Japanese device reviewers advise